These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19328914)

  • 21. Expression of indoleamine 2,3-dioxygenase and infiltration of FOXP3+ regulatory T cells are associated with aggressive features of papillary thyroid microcarcinoma.
    Ryu HS; Park YS; Park HJ; Chung YR; Yom CK; Ahn SH; Park YJ; Park SH; Park SY
    Thyroid; 2014 Aug; 24(8):1232-40. PubMed ID: 24742251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD11b(+) cells in donor-specific transfusion prolonged allogenic skin graft survival through indoleamine 2,3-dioxygenase.
    Ikemoto T; Takita M; Levy MF; Shimada M; Naziruddin B
    Cell Immunol; 2013; 283(1-2):81-90. PubMed ID: 23933136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
    Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
    Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection.
    Laurence JM; Wang C; Zheng M; Cunningham S; Earl J; Tay SS; Allen RD; McCaughan GW; Alexander IE; Bishop GA; Sharland AF
    Liver Transpl; 2009 Feb; 15(2):233-41. PubMed ID: 19177450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunoregulatory function of indoleamine 2, 3 dioxygenase and its application in allotransplantation.
    Jalili RB; Forouzandeh F; Bahar MA; Ghahary A
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):167-79. PubMed ID: 18094439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXP3-positive regulatory cells inside the allograft and the correlation with rejection.
    Naka EL; Ponciano VC; Rangel EB; Cenedeze MA; Pacheco-Silva A; Camara NO
    Transplant Proc; 2006 Dec; 38(10):3202-4. PubMed ID: 17175222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of indoleamine 2,3-dioxygenase in human corneal cells as a local immunosuppressive factor.
    Ryu YH; Kim JC
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4148-52. PubMed ID: 17724200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Forkhead box protein 3 mRNA expression in the peripheral blood of kidney-transplant recipients with acute rejection.
    Wang W; Li XB; Yang XY; Zhang XD
    Chin Med J (Engl); 2011 Jun; 124(12):1775-8. PubMed ID: 21740831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is monitoring of FOXP3 Treg cells in renal transplants during acute cellular rejection episodes useful?
    Batsford S; Dickenmann M; Dürmüller U; Hopfer H; Gudat F; Mihatsch M
    Clin Nephrol; 2011 Feb; 75(2):101-6. PubMed ID: 21255538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients.
    Li Y; Zhao X; Cheng D; Haga H; Tsuruyama T; Wood K; Sakaguchi S; Tanaka K; Uemoto S; Koshiba T
    Transplantation; 2008 Dec; 86(12):1837-43. PubMed ID: 19104431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FoxP3+ T cells can be expanded from rejecting cardiac allografts.
    Dijke E; Velthuis J; Balk A; de Kuiper R; Klepper M; Caliskan K; Weimar W; Baan C
    Transplant Proc; 2006 Dec; 38(10):3233-5. PubMed ID: 17175232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
    Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FOXP3+ regulatory T-cells in renal allografts: correlation with long-term graft function and acute rejection.
    Kollins D; Stoelcker B; Hoffmann U; Bergler T; Reinhold S; Banas MC; Rümmele P; Farkas S; Krämer BK; Banas B
    Clin Nephrol; 2011 Feb; 75(2):91-100. PubMed ID: 21255537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejection.
    Dijke IE; Korevaar SS; Caliskan K; Balk AH; Maat AP; Weimar W; Baan CC
    Transplantation; 2009 Apr; 87(8):1191-200. PubMed ID: 19384166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests.
    Sznurkowski JJ; Żawrocki A; Emerich J; Sznurkowska K; Biernat W
    Gynecol Oncol; 2011 Aug; 122(2):307-12. PubMed ID: 21616522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Local expression of indoleamine 2,3-dioxygenase suppresses T-cell-mediated rejection of an engineered bilayer skin substitute.
    Forouzandeh F; Jalili RB; Hartwell RV; Allan SE; Boyce S; Supp D; Ghahary A
    Wound Repair Regen; 2010; 18(6):614-23. PubMed ID: 20955343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin cells, but not T cells, are resistant to indoleamine 2, 3-dioxygenase (IDO) expressed by allogeneic fibroblasts.
    Forouzandeh F; Jalili RB; Germain M; Duronio V; Ghahary A
    Wound Repair Regen; 2008; 16(3):379-87. PubMed ID: 18471256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FoxP3 positive T cells in graft biopsies from living donor kidney transplants after donor-specific transfusions.
    Eisenberger U; Seifried A; Patey N; Kappeler A; Noel LH; Frey FJ; Körner M
    Transplantation; 2009 Jan; 87(1):138-42. PubMed ID: 19136904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity.
    Hoshi M; Ito H; Fujigaki H; Takemura M; Takahashi T; Tomita E; Ohyama M; Tanaka R; Saito K; Seishima M
    Leuk Res; 2009 Jan; 33(1):39-45. PubMed ID: 18639341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.